The effect of reduced and oxidized pteridine on dopamine-beta-hydroxylase activity.
D001205:Ascorbic Acid / Q000494:pharmacology; D003035:Cobalt / Q000494:pharmacology; D066298:In Vitro Techniques; D007501:Iron / Q000494:pharmacology; D006899:Mixed Function Oxygenases / Q000378:metabolism*; D011621:Pteridines / Q000494:pharmacology*; D014316:Tritium; D014439:Tyramine / Q000378:metabolism
D011621:Pteridines; D014316:Tritium; D003035:Cobalt; D007501:Iron; D006899:Mixed Function Oxygenases; D001205:Ascorbic Acid; D014439:Tyramine